INTERNATIONAL BIOTECHNOLOGY TRUST PLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$380,630
-45.0%
17,0000.0%0.13%
-39.3%
Q2 2023$691,730
-84.6%
17,000
-81.7%
0.21%
-83.2%
Q1 2023$4,504,920
-18.0%
93,000
-35.4%
1.26%
-25.9%
Q4 2022$5,493,600
+420.7%
144,000
+585.7%
1.70%
+402.1%
Q3 2022$1,055,000
-95.0%
21,000
+2394.1%
0.34%
+54.3%
Q2 2022$21,000,000
+3303.6%
842
-99.8%
0.22%
+57.6%
Q1 2022$617,000
-96.5%
411,000
-8.5%
0.14%
-96.5%
Q4 2021$17,884,000
+7.0%
449,0000.0%3.98%
-1.2%
Q3 2021$16,712,000
-11.8%
449,0000.0%4.03%
-19.4%
Q2 2021$18,948,000
-1.9%
449,000
+10.0%
5.00%
-2.1%
Q1 2021$19,319,000
-4.9%
408,000
+22.5%
5.11%
-7.9%
Q4 2020$20,323,000
+45.7%
333,000
+11.4%
5.55%
+23.2%
Q3 2020$13,951,000
-7.8%
299,0000.0%4.50%
-10.5%
Q2 2020$15,135,000
+26.4%
299,000
+11.2%
5.03%
-7.8%
Q1 2020$11,971,000
+118.8%
269,000
+136.0%
5.46%
+176.9%
Q4 2019$5,470,000
-31.5%
114,000
-51.7%
1.97%
-46.6%
Q3 2019$7,982,000
-31.4%
236,000
-8.9%
3.69%
-14.5%
Q2 2019$11,642,000
+28.6%
259,000
+7.7%
4.32%
+29.1%
Q1 2019$9,050,000240,4933.34%
Other shareholders
PTC THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 7,235,196$162,140,7423.42%
Camber Capital Management LP 3,400,000$76,1942.51%
ARMISTICE CAPITAL, LLC 6,150,000$137,821,5002.11%
GREAT POINT PARTNERS LLC 500,000$11,205,0002.04%
COWEN AND COMPANY, LLC 799,511$17,917,0411.25%
GEORGE KAISER FAMILY FOUNDATION 45,816$6,491,2111.22%
SPHERA FUNDS MANAGEMENT LTD. 218,459$4,895,6660.89%
SECTORAL ASSET MANAGEMENT INC 187,016$4,191,0290.82%
Nebula Research & Development LLC 21,858$489,8380.26%
Phocas Financial Corp. 64,701$1,450,0000.21%
View complete list of PTC THERAPEUTICS INC shareholders